Related Experiment Video

Updated: Sep 29, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Antitumor vaccines: is it possible to prevent a tumor?

Pier-Luigi Lollini1, Guido Forni

  • 1Section of Cancer Research, Department of Experimental Pathology, University of Bologna, 40126 Bologna, Italy.

Cancer Immunology, Immunotherapy : CII
|August 31, 2002
PubMed

Insights

This study explores using cancer vaccines preventatively in mice, showing promising results for cancer prevention. However, potential risks like autoimmunity in humans require further preclinical investigation.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Traditional vaccines induce immunity for disease prevention.
  • Cancer vaccines are typically used therapeutically with limited success in advanced disease.
  • This review focuses on preclinical evidence for prophylactic cancer immunology.

Purpose of the Study:

  • To review preclinical evidence supporting the prophylactic use of immunological approaches for cancer prevention.
  • To examine successful immunological cancer prevention in HER-2/neu transgenic mice as a model.
  • To discuss the properties of the HER-2/neu tumor antigen and immune responses in effective prevention.

Main Methods:

  • Review of recent preclinical studies on cancer prevention using immunological methods.
  • Case study of HER-2/neu transgenic mice demonstrating successful cancer prevention.
  • Analysis of tumor antigen properties and induced immune responses.

Main Results:

  • Immunological approaches show potential for cancer prevention in preclinical models.
  • High rates of mammary carcinoma prevention observed in HER-2/neu transgenic mice.
  • Effective preventive treatments involve specific tumor antigens and immune responses.

Conclusions:

  • Preclinical evidence supports the potential of immunological strategies for cancer prevention.
  • While promising, the risk of inducing autoimmunity in humans necessitates careful preclinical evaluation.
  • Animal models are crucial for addressing safety concerns before human application.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...